The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

Immunotherapies that mobilise a patient’s immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell...

Cutting off cancer cells’ access to fat may help a specific type of cancer treatment work more effectively, according to a study by Van Andel...

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...

In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...

Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumour is still...

In healthy brains, immune cells called microglia patrol for damage, clearing away debris and harmful proteins. But in the presence of the APOE4...

Determining how to treat cancer often depends on understanding the genes driving a tumor’s growth. Traditionally, this requires genetic sequencing,...

CRISPR Therapeutics reports mixed third-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is progressing well.

There are billions of tiny packets of cellular material called extracellular vesicles (EVs) that cells produce and release into each person’s blood,...